Vasopressors for hypotensive shock (Q24186138)

1 July 2019

meta-analysis

0 references

title

Vasopressors for hypotensive shock (English)

1 reference

1 July 2019

0 references

1 reference

1 July 2019

author name string

Gunnar Gamper

1 reference

1 July 2019

Christof Havel

1 reference

1 July 2019

Heidrun Losert

1 reference

1 July 2019

Marcus Müllner

1 reference

1 July 2019

Harald Herkner

1 reference

1 July 2019

publication date

15 February 2016

1 reference

1 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

1 July 2019

volume

1 reference

1 July 2019

page(s)

CD003709

1 reference

1 July 2019

Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

A comparison of epinephrine and norepinephrine in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Efficacy and safety of dopamine versus norepinephrine in the management of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

The effects of vasopressin on acute kidney injury in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressin versus norepinephrine infusion in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Beneficial effects of short-term vasopressin infusion during severe septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Response to dobutamine and dopamine in the hypotensive very preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Early use of vasopressors after injury: caution before constriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Comparative study of dopamine and norepinephrine in the management of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Goal-directed resuscitation for patients with early septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

High versus Low Blood-Pressure Target in Patients with Septic Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressor and inotropic support in septic shock: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Utility of the shock index in predicting mortality in traumatically injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasoactive drugs for vasodilatory shock in ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Visualizing the flow of evidence in network meta-analysis and characterizing mixed treatment comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Survey of the use of catecholamines by French physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressor use in septic shock: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Effect of norepinephrine on the outcome of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

A randomized trial of protocol-based care for early septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Arcsine test for publication bias in meta-analyses with binary outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Evaluating the quality of evidence from a network meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Dopamine versus dobutamine for hypotensive preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Epidemiology of sepsis in Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Should we target blood pressure in sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressors in septic shock: a systematic review and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Vasopressors for hypotensive shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB4

[Vasopressin for therapy of persistent traumatic hemorrhagic shock: The VITRIS.at study]

21 January 2018

1 reference

12 December 2020

The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study

1 reference

12 December 2020

Vasopressors for shock

1 reference

12 December 2020

[A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock]

1 reference

12 December 2020

Low-dose vasopressin in the treatment of vasodilatory septic shock

1 reference

12 December 2020

A graphical tool for locating inconsistency in network meta-analyses.

1 reference

12 December 2020

Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial.

1 reference

12 December 2020

Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU

1 reference

12 December 2020

Terlipressin in the treatment of late phase catecholamine-resistant septic shock

1 reference

12 December 2020

Dopamine and dobutamine in septic shock a comparison

1 reference

12 December 2020

Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study

1 reference

12 December 2020

A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement.

1 reference

12 December 2020

Impact of low-dose vasopressin on trauma outcome: prospective randomized study

1 reference

12 December 2020

Regional blood flow and oxygen transport in septic shock

1 reference

12 December 2020

Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212].

1 reference

12 December 2020

Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward.

1 reference

12 December 2020

Sepsis terminology in pediatrics

1 reference

12 December 2020

Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock

1 reference

12 December 2020

Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock

1 reference

12 December 2020

Comparative study of angiotensin and nor-adrenaline in hypotensive states (shock)

1 reference

12 December 2020

Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.

1 reference

12 December 2020

Network meta-analysis, electrical networks and graph theory

1 reference

12 December 2020

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

12 December 2020

Incidence and prognosis of sustained arrhythmias in critically ill patients

1 reference

12 December 2020

[Use of vasopressin to correct hemodynamic disorders in patients with abdominal sepsis]

1 reference

12 December 2020

Epinephrine-induced lactic acidosis following cardiopulmonary bypass

1 reference

12 December 2020

10.1002/14651858.CD003709.PUB4

Identifiers

DOI

1 reference

1 July 2019

OpenCitations bibliographic resource ID

1793161

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

1 July 2019

PubMed publication ID

26878401

1 reference

1 July 2019